BRONCHODILATOR AND ANTI-INFLAMMATORY ACTIVITIES OF ADHATODA SCHIMPERIANA

Main Article Content

Ashenafi Assefa
Kelbessa Urga
Daniel Melaku
Mulugeta Guta
Walelign Mekonnen

Abstract

BACKGROUND: Adhatoda schimperiana is a plant believed to have several therapeutic effects including anti-asthmatic properties. The objective of this study was to investigate the bronchodialatory, anti-inflammatory effects and toxicity of the hydromethanolic extract of leaves of this plant. METHODS: The isolated guinea-pig trachea pre-contracted with histamine and acetylcholine was used to study the relaxation of hydromethanolic extract of leaves Adhatoda shimperiana. Salbutamol and atropine were used as standards. The effect of the hydromethanol extract of leaves of Adhatoda schimperiana on carageenin-induced acute inflammation was evaluated by the rat hind paw edema method. Oral and interaperitoneal acute toxicity studies of the extract were performed on mice. RESULTS: The hydromethanolic extract of Adhatoda schimperiana inhibited contractions of guinea pig tracheal chains induced by acetylcholine and histamine with an EC 50 of 4.66 mg/ml and 5.92 mg/ml, respectively. Salbutamol and atropine also showed similar concentration dependent relaxation of the tracheal chains pre-contracted with both acetylcholine and histamine. The inhibitory activity of atropine was lower than the extract and salbutamol. The extract exhibited a moderate degree of anti- inflammatory activity. The LD 50 of the extract for oral acute toxicity study was found to be 1286.76 mg/kg with 95 % confidence limit of 1161.9 – 1418.0. The plant extract therefore presents a relatively low acute toxicity. CONCLUSION: The results of this study show anti-inflammatory activity and a relatively potent relaxant (bronchodialatory) effect of Adhatoda schimperiana on the tracheal chain of the guinea pig. These activities justify the traditional use of this plant in the treatment of bronchoconstrictive diseases. More detailed studies are required to investigate the mechanism of action, the toxicity and the therapeutic utility of Adhatoda schimperiana for further development towards a proper drug.

Article Details

Section
Original Article
Author Biographies

Ashenafi Assefa, Addis Ababa University

Department of Drug Research, Ethiopia Health and Nutrition Research Institution, P.O. Box 1242 or 5654, Addis Ababa e-

Kelbessa Urga, Jimma University

Department of Drug Research, Ethiopia Health and Nutrition Research Institution, P.O. Box 1242 or 5654, Addis Ababa e-
mail:ddr@ethionet.et, Fax: 0112754744 or 0112757722

Daniel Melaku, Addis Ababa University

Department of Drug Research, Ethiopia Health and Nutrition Research Institution, P.O. Box 1242 or 5654, Addis Ababa e- mail:ddr@ethionet.et, Fax: 0112754744 or 0112757722

Mulugeta Guta, Addis Ababa University

Department of Drug Research, Ethiopia Health and Nutrition Research Institution, P.O. Box 1242 or 5654, Addis Ababa e-
mail:ddr@ethionet.et, Fax: 0112754744 or 0112757722

Walelign Mekonnen, Addis Ababa University

Department of Drug Research, Ethiopia Health and Nutrition Research Institution, P.O. Box 1242 or 5654, Addis Ababa e-
mail:ddr@ethionet.et, Fax: 0112754744 or 0112757722